NovaStar is the latest lender to assume the belly-up position.
This analysis is my vote for the "Stop beating around the bush and just tell it like it is" quote of the day:
"Our opinion that NovaStar's financial viability remains highly uncertain has increased," Friedman Billings Ramsey analyst Scott Valentin wrote in a client note. Valentin's price target on NovaStar's stock is zero."